Additional molecular testing of saliva specimens improves the detection of respiratory viruses
- PMID: 28588283
- PMCID: PMC5520312
- DOI: 10.1038/emi.2017.35
Additional molecular testing of saliva specimens improves the detection of respiratory viruses
Abstract
Emerging infectious diseases in humans are often caused by respiratory viruses such as pandemic or avian influenza viruses and novel coronaviruses. Microbiological testing for respiratory viruses is important for patient management, infection control and epidemiological studies. Nasopharyngeal specimens are frequently tested, but their sensitivity is suboptimal. This study evaluated the incremental benefit of testing respiratory viruses in expectorated saliva using molecular assays. A total of 258 hospitalized adult patients with suspected respiratory infections were included. Their expectorated saliva was collected without the use of any special devices. In the first cohort of 159 patients whose nasopharyngeal aspirates (NPAs) tested positive for respiratory viruses during routine testing, the viral load was measured using quantitative reverse transcription PCR. Seventeen percent of the patients (27/159) had higher viral loads in the saliva than in the NPA. The second cohort consisted of 99 patients whose NPAs tested negative for respiratory viruses using a direct immunofluorescence assay. Their NPA and saliva specimens were additionally tested using multiplex PCR. In these patients, the concordance rate by multiplex PCR between NPA and saliva was 83.8%. Multiplex PCR detected viruses in saliva samples from 16 patients, of which nine (56.3%) had at least one virus that was not detected in the NPA. Decisions on antiviral or isolation precautions would be affected by salivary testing in six patients. Although NPAs have high viral loads and remain the specimen of choice for most patients with respiratory virus infections, supplementary molecular testing of saliva can improve the clinical management of these patients.
Figures
Comment in
-
SARS-CoV-2: What can saliva tell us?Oral Dis. 2021 Apr;27 Suppl 3(Suppl 3):746-747. doi: 10.1111/odi.13365. Epub 2020 May 11. Oral Dis. 2021. PMID: 32311181 Free PMC article. No abstract available.
Similar articles
-
Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children.J Clin Virol. 2008 May;42(1):65-9. doi: 10.1016/j.jcv.2007.12.003. Epub 2008 Feb 1. J Clin Virol. 2008. PMID: 18242124
-
[Simultaneous detection of respiratory viruses and influenza A virus subtypes using multiplex PCR].Mikrobiyol Bul. 2014 Oct;48(4):652-60. doi: 10.5578/mb.8221. Mikrobiyol Bul. 2014. PMID: 25492660 Turkish.
-
Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study.Clin Microbiol Infect. 2019 Mar;25(3):372-378. doi: 10.1016/j.cmi.2018.06.009. Epub 2018 Jun 12. Clin Microbiol Infect. 2019. PMID: 29906597
-
Molecular diagnosis of respiratory virus infections.Crit Rev Clin Lab Sci. 2011 Sep-Dec;48(5-6):217-49. doi: 10.3109/10408363.2011.640976. Crit Rev Clin Lab Sci. 2011. PMID: 22185616 Review.
-
[Application of molecular methods in the diagnosis and epidemiological study of viral respiratory infections].Enferm Infecc Microbiol Clin. 2008 Jul;26 Suppl 9:15-25. doi: 10.1016/s0213-005x(08)76537-6. Enferm Infecc Microbiol Clin. 2008. PMID: 19195443 Free PMC article. Review. Spanish.
Cited by
-
Saliva as an Alternative Specimen for Molecular COVID-19 Testing in Community Settings and Population-Based Screening.Infect Drug Resist. 2020 Oct 1;13:3393-3399. doi: 10.2147/IDR.S275152. eCollection 2020. Infect Drug Resist. 2020. PMID: 33061486 Free PMC article.
-
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.Emerg Microbes Infect. 2020 Dec;9(1):1356-1359. doi: 10.1080/22221751.2020.1775133. Emerg Microbes Infect. 2020. PMID: 32459137 Free PMC article.
-
Posterior Oropharyngeal Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Clin Infect Dis. 2020 Dec 31;71(11):2939-2946. doi: 10.1093/cid/ciaa797. Clin Infect Dis. 2020. PMID: 32562544 Free PMC article.
-
Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis.JMIR Public Health Surveill. 2024 Sep 24;10:e54503. doi: 10.2196/54503. JMIR Public Health Surveill. 2024. PMID: 39316785 Free PMC article.
-
Overview of Upper Airway Management During COVID-19 Outbreak: Head and Neck Surgeon's Perspective.J Craniofac Surg. 2020 Sep;31(6):e644-e649. doi: 10.1097/SCS.0000000000006798. J Craniofac Surg. 2020. PMID: 32649566 Free PMC article. Review.
References
-
- Luyt CE, Brechot N, Chastre J. What role do viruses play in nosocomial pneumonia? Curr Opin Infect Dis 2014; 27: 194–199. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical